Emerging Basal Insulins for Diabetes
Program Goals
The Barrier of Hypoglycemia in Diabetes
Hypoglycemia and Cardiovascular Events
Insulin Glargine U-300
Reductions in Nocturnal Hypoglycemia With U-300
PK/PD Profile Glargine U-300
EDITION I-III (Meta-analysis) Nocturnal Hypoglycemia (Rates)
EDITION I-III (Meta-analysis) Body Weight
EDITION I-III (Meta-analysis) Basal Insulin Doses
Insulin Degludec An Ultra-Long-Acting Basal Insulin Analog
Insulin Degludec Pharmacodynamics at Steady State
Insulin Degludec Duration of Action
Insulin Degludec Low Within-Patient Variability
Insulin Degludec vs Insulin Glargine Hypoglycemia Results
Emerging Intensification Strategy
Peglispro (BIL)*
Key Takeaway Points of Next-Generation Basal Insulin Analogs
Abbreviations
Abbreviations (cont)
References
References (cont)
References (cont)
References (cont)
References (cont)
References (cont)